HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cancer incidence of 2,4-D production workers.

Abstract
Despite showing no evidence of carcinogenicity in laboratory animals, the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) has been associated with non-Hodgkin lymphoma (NHL) in some human epidemiology studies, albeit inconsistently. We matched an existing cohort of 2,4-D manufacturing employees with cancer registries in three US states resulting in 244 cancers compared to 276 expected cases. The Standardized Incidence Ratio (SIR) for the 14 NHL cases was 1.36 (95% Confidence Interval (CI) 0.74-2.29). Risk estimates were higher in the upper cumulative exposure and duration subgroups, yet not statistically significant. There were no clear patterns of NHL risk with period of hire and histology subtypes. Statistically significant results were observed for prostate cancer (SIR = 0.74, 95% CI 0.57-0.94), and "other respiratory" cancers (SIR = 3.79, 95% CI 1.22-8.84; 4 of 5 cases were mesotheliomas). Overall, we observed fewer cancer cases than expected, and a non statistically significant increase in the number of NHL cases.
AuthorsCarol Burns, Kenneth Bodner, Gerard Swaen, James Collins, Kathy Beard, Marcia Lee
JournalInternational journal of environmental research and public health (Int J Environ Res Public Health) Vol. 8 Issue 9 Pg. 3579-90 (09 2011) ISSN: 1660-4601 [Electronic] Switzerland
PMID22016704 (Publication Type: Journal Article)
Chemical References
  • Air Pollutants, Occupational
  • Herbicides
  • 2,4-Dichlorophenoxyacetic Acid
Topics
  • 2,4-Dichlorophenoxyacetic Acid (toxicity)
  • Adult
  • Aged
  • Air Pollutants, Occupational (toxicity)
  • Chemical Industry
  • Cohort Studies
  • Herbicides (toxicity)
  • Humans
  • Incidence
  • Lymphoma, Non-Hodgkin (epidemiology)
  • Male
  • Michigan (epidemiology)
  • Middle Aged
  • Occupational Exposure
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: